免疫检查点阻断通过扩增效应 CD8⁺ T 细胞克隆增强淋巴细胞清除性化疗诱导的抗肿瘤免疫
Immune Checkpoint Blockade Augments Lymphodepleting Chemotherapy-Induced Antitumor Immunity by Expanding Effector CD8+ T-cell Clones.
CELL INTELLIGENCE · 肿瘤细胞治疗研究
肿瘤细胞治疗研究
英文原题:Signal regulatory protein γ is associated with an exhaustion-prone immune microenvironment in metastatic melanoma.
Signal regulatory protein γ is associated with an exhaustion-prone immune microenvironment in metastatic melanoma.
分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。
识别转移性黑色素瘤免疫微环境重塑的决定因素对于改善预后评估和治疗分层至关重要。在本研究中,我们通过数据库挖掘、单细胞转录组学和免疫组化(IHC)验证相结合的方式,检测了信号调节蛋白γ(SIRPG)在皮肤黑色素瘤(SKCM)中的表达及其临床意义。与正常皮肤相比,SIRPG在SKCM组织中显著升高,且较高的表达水平与延长的总生存期和无病生存期相关。功能和通路分析显示,SIRPG与免疫相关过程密切相关,相关性分析表明SIRPG表达与免疫细胞浸润和检查点分子表达均存在强关联,且这些关联在转移灶中比在原发肿瘤中更为显著。单细胞RNA测序进一步将SIRPG表达主要定位于转移性病灶内的CD8+耗竭T细胞,多重免疫荧光在蛋白水平证实了SIRPG与程序性细胞死亡蛋白1(PD-1)的共表达富集。
综上所述,这些发现表明SIRPG参与了转移性黑色素瘤中易耗竭的免疫抑制微环境的建立,并凸显了其作为疾病进展和免疫治疗反应生物标志物的潜在价值。
Identifying determinants of immune microenvironment remodeling in metastatic melanoma is critical for improving prognostic assessment and therapeutic stratification. In this study, we examined the expression and clinical significance of signal regulatory protein γ (SIRPG) in skin cutaneous melanoma (SKCM) through a combination of database mining, single-cell transcriptomics, and immunohistochemical (IHC) validation. SIRPG was significantly elevated in SKCM tissues compared with normal skin, and higher expression levels were associated with prolonged overall and disease-free survival.
Functional and pathway analyses revealed that SIRPG was intimately linked to immune-related processes, and correlative analyses demonstrated strong associations between SIRPG expression and both immune cell infiltration and checkpoint molecule expression, with these associations being more pronounced in metastases than in primary tumors.
Single-cell RNA sequencing further localized SIRPG expression predominantly to CD8 + exhausted T cells within metastatic lesions, and multiplex immunofluorescence confirmed enriched co-expression of SIRPG and programmed cell death protein 1 (PD-1) at the protein level. Taken together, these findings implicate SIRPG in the establishment of an exhaustion-prone immunosuppressive microenvironment in metastatic melanoma and highlight its potential utility as a biomarker for disease progression and immunotherapeutic response.
MEMBER ACCOUNT
登录成功会直接打开下一页。